State Ledger
Company profile

ABBOTT LABORATORIES CIK 1800

Ticker
ABT (NYSE)
Industry
Pharmaceutical Preparations
Headquarters
Abbott Park, IL 60064-3500
Fiscal year end
2025 (FY)
Market Data
Close
$102.69
Change
+$0.86
Change %
0.84%
Volume
562,031

ABT · trading date Oct 13, 2026 · previous close $101.83 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
$44.33B
Net income
$6.52B
Total assets
$86.71B
Total liabilities
—
Stockholders' equity
$52.13B
Cash & equivalents
$8.52B
Operating income
$8.05B
Operating cash flow
$9.57B
Capital expenditures
$2.17B

Fiscal year 2025, via 10-K filed 2026-02-20. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
18.2%
Net margin
14.7%
Free cash flow
$7.40B
Free cash flow margin
16.7%
Liabilities / assets
—
Equity / assets
60.1%
CapEx / revenue
4.9%
Operating cash flow / net income
1.47×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 $44.33B $6.52B $86.71B — $52.13B
2024 $41.95B $13.40B $81.41B — $47.66B
2023 $40.11B $5.72B $73.21B — $38.60B
2022 $43.65B $6.93B $74.44B — $36.69B
2021 $43.08B $7.07B $75.20B — $35.80B
Company Details
SIC code
2834
State of incorporation
IL
Active filer
Yes
Most recent SEC filing
Form 4
2026-09-03
Financials filed via
Form 10-K
filed 2026-02-20

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Abbott Park, IL 60064-3500
100 ABBOTT PARK ROAD
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:29 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Illinois — Public Companies